These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 34464223)

  • 1. Pharmacotherapeutic agents for the management of COVID-19 patients with preexisting cardiovascular disease.
    Khan M; Singh GK; Abrar S; Ganeshan R; Morgan K; Harky A
    Expert Opin Pharmacother; 2021 Dec; 22(18):2455-2474. PubMed ID: 34464223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 and its long-term impact on the cardiovascular system.
    Philip B; Mukherjee P; Khare Y; Ramesh P; Zaidi S; Sabry H; Harky A
    Expert Rev Cardiovasc Ther; 2023 Mar; 21(3):211-218. PubMed ID: 36856339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of SARS-CoV-2 treatment on the cardiovascular system: an updated review.
    Akkaif MA; Sha'aban A; Cesaro A; Jaber AAS; Vergara A; Yunusa I; Jatau AI; Mohammed M; Govindasamy GS; Al-Mansoub MA; Sheikh Abdul Kader MA; Ibrahim B
    Inflammopharmacology; 2022 Aug; 30(4):1143-1151. PubMed ID: 35701719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 and cardiac injury: clinical manifestations, biomarkers, mechanisms, diagnosis, treatment, and follow up.
    Tajbakhsh A; Gheibi Hayat SM; Taghizadeh H; Akbari A; Inabadi M; Savardashtaki A; Johnston TP; Sahebkar A
    Expert Rev Anti Infect Ther; 2021 Mar; 19(3):345-357. PubMed ID: 32921216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 pathophysiology and its clinical implications: An integrative overview of the pharmacotherapeutic management of COVID-19.
    Tsatsakis A; Calina D; Falzone L; Petrakis D; Mitrut R; Siokas V; Pennisi M; Lanza G; Libra M; Doukas SG; Doukas PG; Kavali L; Bukhari A; Gadiparthi C; Vageli DP; Kofteridis DP; Spandidos DA; Paoliello MMB; Aschner M; Docea AO
    Food Chem Toxicol; 2020 Dec; 146():111769. PubMed ID: 32979398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronavirus Disease 2019 and the Cerebrovascular-Cardiovascular Systems: What Do We Know So Far?
    Larson AS; Savastano L; Kadirvel R; Kallmes DF; Hassan AE; Brinjikji W
    J Am Heart Assoc; 2020 Jul; 9(13):e016793. PubMed ID: 32393136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute respiratory distress syndrome (ARDS) caused by the novel coronavirus disease (COVID-19): a practical comprehensive literature review.
    Montenegro F; Unigarro L; Paredes G; Moya T; Romero A; Torres L; López JC; González FEJ; Del Pozo G; López-Cortés A; Diaz AM; Vasconez E; Cevallos-Robalino D; Lister A; Ortiz-Prado E
    Expert Rev Respir Med; 2021 Feb; 15(2):183-195. PubMed ID: 32902367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of COVID-19 on Cardiovascular Disease.
    Vosko I; Zirlik A; Bugger H
    Viruses; 2023 Feb; 15(2):. PubMed ID: 36851722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular biomarkers in patients with COVID-19.
    Mueller C; Giannitsis E; Jaffe AS; Huber K; Mair J; Cullen L; Hammarsten O; Mills NL; Möckel M; Krychtiuk K; Thygesen K; Lindahl B;
    Eur Heart J Acute Cardiovasc Care; 2021 May; 10(3):310-319. PubMed ID: 33655301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Issues of Cardiovascular Risk Management in People With Diabetes in the COVID-19 Era.
    Ceriello A; Standl E; Catrinoiu D; Itzhak B; Lalic NM; Rahelic D; Schnell O; Škrha J; Valensi P;
    Diabetes Care; 2020 Jul; 43(7):1427-1432. PubMed ID: 32409501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cardiovascular implications of SARS-CoV-2 infection: A literature review].
    García-Saavedra MB; Rosales-Gutiérrez RR; Valverde E; Chumbes-Aguirre M; Alvarado R; Polo R; Azañero R; Chávez C
    Medwave; 2020 Aug; 20(7):e8008. PubMed ID: 32877391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Centrality of Obesity in the Course of Severe COVID-19.
    Liu D; Zhang T; Wang Y; Xia L
    Front Endocrinol (Lausanne); 2021; 12():620566. PubMed ID: 33776917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensive care for seriously ill patients affected by novel coronavirus sars - CoV - 2: Experience of the Crema Hospital, Italy.
    Zuccon W; Comassi P; Adriani L; Bergamaschini G; Bertin E; Borromeo R; Corti S; De Petri F; Dolci F; Galmozzi A; Gigliotti A; Gualdoni L; Guerra C; Khosthiova A; Leati G; Lupi G; Moscato P; Perotti V; Piantelli M; Ruini A; Sportelli S; Susca M; Troiano C; Benelli G; Buscarini E; Canetta C; Merli G; Scartabellati A; Melilli B S C G; Sfogliarini R; Pellegatta G; Viganò G
    Am J Emerg Med; 2021 Jul; 45():156-161. PubMed ID: 33046317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular Tropism and Sequelae of SARS-CoV-2 Infection.
    Dmytrenko O; Lavine KJ
    Viruses; 2022 May; 14(6):. PubMed ID: 35746609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacotherapeutic considerations for the management of cardiovascular diseases among hospitalized COVID-19 patients.
    Kow CS; Thiruchelvam K; Hasan SS
    Expert Rev Cardiovasc Ther; 2020 Aug; 18(8):475-485. PubMed ID: 32700573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Evolving Phenotypes of Cardiovascular Disease during COVID-19 Pandemic.
    Correale M; Croella F; Leopizzi A; Mazzeo P; Tricarico L; Mallardi A; Fortunato M; Magnesa M; Ceci V; Puteo A; Iacoviello M; Di Biase M; Brunetti ND
    Cardiovasc Drugs Ther; 2023 Apr; 37(2):341-351. PubMed ID: 34328581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EACTA/SCA Recommendations for the Cardiac Anesthesia Management of Patients With Suspected or Confirmed COVID-19 Infection: An Expert Consensus From the European Association of Cardiothoracic Anesthesiology and Society of Cardiovascular Anesthesiologists With Endorsement From the Chinese Society of Cardiothoracic and Vascular Anesthesiology.
    Guarracino F; Shernan SK; Tahan ME; Bertini P; Stone ME; Kachulis B; Paternoster G; Mukherjee C; Wouters P; Rex S
    J Cardiothorac Vasc Anesth; 2021 Jul; 35(7):1953-1963. PubMed ID: 33766471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19).
    Bourgonje AR; Abdulle AE; Timens W; Hillebrands JL; Navis GJ; Gordijn SJ; Bolling MC; Dijkstra G; Voors AA; Osterhaus AD; van der Voort PH; Mulder DJ; van Goor H
    J Pathol; 2020 Jul; 251(3):228-248. PubMed ID: 32418199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology, risk factors and prognosis of cardiovascular disease in the Coronavirus Disease 2019 (COVID-19) pandemic era: a systematic review.
    Pepera G; Tribali MS; Batalik L; Petrov I; Papathanasiou J
    Rev Cardiovasc Med; 2022 Jan; 23(1):28. PubMed ID: 35092220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential Effects of Coronaviruses on the Cardiovascular System: A Review.
    Madjid M; Safavi-Naeini P; Solomon SD; Vardeny O
    JAMA Cardiol; 2020 Jul; 5(7):831-840. PubMed ID: 32219363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.